Biotech Values

[exwannabe]

DueD, MNTA (and any) shorts shares.

Often these shares are part of a more complex position involving options and/or debt. As such, the analysis might be much more involved than you state.

P.S., I do agree that someone with a true short position in MNTA would be on drugs not to cover some/all [or at least use the profits to hedge up]. This would be the same as any former DNDN long who failed to cash some out after the A/C meeting.